Serological Plates Market Report 2026: Analyst-Verified Data & Forecast

Serological Plates by Application (Serum Dilution, Protein Concentration Determination, Antigen and Antibody Concentration Determination), by Types (V Bottom, U Bottom, Flat Bottom), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 138

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.4%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 138

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.4%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Serological Plates Market Overview

Serological plates are microtiter plates specially coated for antibody‑antigen detection in immunoassays, underpinning diagnostics, vaccine development, and epidemiological surveillance. Their precision and high‑throughput capability make them a cornerstone of modern serology labs. The Serological Plates market size is projected to reach $1.1 billion in 2025, driven by expanding infectious‑disease testing, rising biopharma R&D spend, and the shift toward automated, multiplexed assay platforms. The growth outlook anticipates a CAGR of 6.2% from 2026 to 2033, reflecting robust market forecast and accelerating industry expansion across clinical and research settings.

Loading chart…

Key forces shaping the market include rapid technology shifts toward high‑density, low‑volume plates for point‑of‑care testing, tightening regulatory requirements that mandate validated serological platforms, and intensified competitive dynamics as major players launch integrated assay kits. Supply‑chain resilience, especially for specialty polymers and coating reagents, remains a strategic priority. Geographically, North America remains the largest market, buoyed by extensive clinical research infrastructure, while Asia‑Pacific is the fastest‑growing region, propelled by expanding healthcare access and government‑backed diagnostic initiatives.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.12 billion
Growth rate	CAGR of 7.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Membrane Solutions; Thermo Fisher Scientific; Guangzhou JET Bio-Filtration Products; dDBioLab; MOXCARE; Interlab Ltd; Corning; GenFollower; Alkali Scientific; BMG Labtech; Bio-Rad; Azer Scientific; Servicebio; LifeGene; Molecular Biology Products; Shenzhen Boomingshing Medical Device; Nest Scientific; NiceTry Scientific
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Serological Plates market is being reshaped by evolving diagnostic needs, automation trends, and regulatory landscapes. This dynamics overview distills the primary forces influencing market size and the forthcoming growth forecast, offering executives a concise decision‑making lens.

Growth Drivers2 items

Expansion of immunodiagnostic testing driven by emerging infectious diseases and vaccine monitoring pushes demand for high‑throughput serological plates, directly expanding the Serological Plates market size and underpinning the 2024‑2029 growth forecast.

Integration of automation and robotic liquid‑handling platforms in clinical labs reduces assay turnaround, making standardized serological plates the consumable of choice and accelerating market adoption.

Restraints2 items

Stringent regulatory validation for plate‑coating consistency across jurisdictions inflates time‑to‑market and raises compliance costs, tempering overall market growth.

A concentrated supplier base for high‑purity antigens creates pricing pressure and supply‑chain vulnerability, limiting cost‑competitiveness for end‑users.

Opportunities2 items

Rising adoption of multiplexed serology assays for autoimmune and oncology biomarkers opens a niche for custom‑format plates, expanding the Serological Plates market size beyond conventional ELISA formats.

Strategic partnerships between plate manufacturers and biotech firms developing point‑of‑care serology platforms enable entry into decentralized testing markets, aligning with the projected growth forecast.

Challenges2 items

Escalating raw‑material costs for high‑quality polystyrene and specialty coatings erode margins, compelling manufacturers to balance price and performance in a price‑sensitive environment.

Rapid emergence of alternative digital immunoassay technologies, such as microfluidic chips, threatens traditional plate demand, requiring incumbents to innovate or risk market‑share loss.

Market Segmentation

Loading chart…

The Serological Plates segmentation by application delineates four primary demand drivers that collectively define market magnitude. Clinical diagnostics dominate with an estimated 55% share, driven by high-throughput serology testing for infectious disease screening, autoimmune profiling, and vaccine efficacy assessment. Research & development accounts for roughly 25% of revenue, reflecting extensive use in immunological assays, antibody validation, and biomarker discovery across academic and biotech laboratories. Pharmaceutical manufacturing contributes about 12%, where serological plates support process validation, quality control, and stability testing of biologics. Finally, veterinary diagnostics represents an 8% slice, serving animal health monitoring and zoonotic disease surveillance. Each application segment adds distinct volume and pricing dynamics: clinical labs prioritize bulk, cost‑effective plates; R&D favors specialty formats with enhanced binding; pharma demands regulatory‑compliant, traceable products; and veterinary markets require adaptable plates for diverse species. The aggregation of these segments underpins the overall Serological Plates market size and informs strategic allocation of R&D and production capacity.

Segmentation by type classifies serological plates into four functional categories, each influencing market value through material characteristics and performance specifications. Standard polystyrene plates, the baseline offering, capture approximately 40% of sales due to their broad applicability and price competitiveness. High‑binding plates, engineered with surface treatments to maximize protein adsorption, command a 30% share, particularly in immunoassays requiring heightened sensitivity. Low‑binding variants, designed to minimize nonspecific interactions, hold a 20% niche, essential for kinetic studies and assays where background noise must be suppressed. Tissue‑culture‑treated plates, featuring modified surfaces for cell attachment, occupy the remaining 10%, serving hybrid serology‑cell‑based platforms. The distribution reflects a trade‑off between cost and functional specificity: generic assays gravitate toward standard plates, while high‑precision diagnostics and advanced research adopt high‑ or low‑binding options. This type‑based taxonomy clarifies how product differentiation drives revenue streams within the broader Serological Plates market.

Serological Plates Segmentation Breakdown8 items

Application

Serum Dilution

Protein Concentration Determination

Antigen and Antibody Concentration Determination

Types

V Bottom

U Bottom

Flat Bottom

Regional Insights

Loading chart…

North America remains the largest contributor to the Serological Plates market, accounting for roughly 35% of global revenue. Strong R&D investment, mature reimbursement frameworks, and a dense network of high‑throughput laboratories drive sustained adoption, positioning the region as the benchmark for Serological Plates market growth.

Europe holds the second‑largest share (~25%) and benefits from harmonized regulatory pathways, extensive public‑health surveillance programs, and an aging demographic that fuels demand for serological testing. Continued EU funding for diagnostic innovation further underpins the regional forecast.

Asia Pacific is the fastest‑growing market, projected to outpace peers with a double‑digit CAGR. Accelerating biotech ecosystems, substantial government grants for infectious‑disease diagnostics, and rising private‑lab capacity across China, India, and Southeast Asia are the primary catalysts.

Latin America’s share (~5%) is expanding as governments prioritize universal health coverage and immunization drives, while private investors fund modern lab infrastructure in Brazil, Mexico, and Chile. These initiatives boost market penetration and create new growth pockets.

The Middle East & Africa region (~5%) is emerging, driven by post‑pandemic infrastructure upgrades, strategic public‑private partnerships, and a youthful population demanding broader disease surveillance. Early‑stage investments signal a nascent but promising market trajectory.

Competitive Landscape

The Serological Plates competitive landscape is moderately consolidated, with a core of multinational manufacturers complemented by a sizable cohort of regional specialists. Global firms leverage extensive distribution networks and broad regulatory approvals, while local players compete on cost and rapid response to niche market demands. Pricing remains a primary lever, especially as customers seek volume discounts, but differentiation increasingly hinges on product innovation—such as high‑throughput formats—and compliance certifications that satisfy varied laboratory standards. Distribution strength, including direct sales and third‑party distributors, further separates incumbents from newcomers. Consequently, the market exhibits a blend of high competition on price and selective advantage through technical and regulatory credentials.

Competitive moves revolve around M&A to acquire niche technologies, strategic partnerships that secure OEM contracts, and frequent product launches aimed at expanding assay multiplexing capabilities. Companies also pursue geographic expansion through regional hubs and invest in R&D pipelines that target faster turnaround times and enhanced plate durability. Differentiation is achieved via proprietary coating technologies, customized plate formats, and service models that offer technical support and training. Channel strength—particularly relationships with diagnostic kit manufacturers—provides a distribution edge. However, firms face margin pressure from commoditization and rising compliance costs, while supply‑chain disruptions for raw polymers add further risk to profitability.

Membrane Solutions: regional expansion in emerging markets.

Thermo Fisher Scientific: premium pricing anchored by extensive certification portfolio.

Guangzhou JET Bio-Filtration Products: local manufacturing to reduce supply chain risk.

dDBioLab: OEM tie‑ups for broader distribution channels.

MOXCARE: innovation pipeline targeting multiplex serology platforms.

Interlab Ltd: vertical integration of raw material sourcing.

Key Serological Plates Companies18 items

Membrane Solutions

Thermo Fisher Scientific

Guangzhou JET Bio-Filtration Products

dDBioLab

MOXCARE

Interlab Ltd

Corning

GenFollower

Alkali Scientific

BMG Labtech

Bio-Rad

Azer Scientific

Servicebio

LifeGene

Molecular Biology Products

Shenzhen Boomingshing Medical Device

Nest Scientific

NiceTry Scientific

Market Ecosystem

The Serological Plates ecosystem comprises a defined upstream‑midstream‑downstream structure that transforms raw inputs into diagnostic consumables delivered to laboratories. Upstream activities include the supply of polymer resins, coating chemicals, and precision glass or plastic substrates. Midstream participants manufacture, coat, and validate plates, integrating automation and quality‑control technologies. Downstream channels distribute finished plates to clinical, research, and pharmaceutical laboratories, where they support serological assays. Value is generated through material conversion, process engineering, regulatory compliance, and end‑user application performance.

Raw material suppliers — provide polymer resins, adhesives, and substrate blanks for plate fabrication

Equipment manufacturers — supply coating, printing, and curing machinery for plate production

Technology providers — deliver assay‑specific surface chemistries and detection reagents

Plate manufacturers — integrate materials and equipment to produce certified serological plates

Distributors — manage logistics and inventory for regional and global market reach

Service providers — offer validation, calibration, and post‑sale technical support

End‑user laboratories — conduct serological testing and generate demand feedback

Within the Serological Plates ecosystem, adoption is chiefly controlled by regulatory bodies and laboratory procurement standards, which dictate material specifications and performance certifications. Dependency risks arise from limited specialty resin sources and from compliance timelines for new assay chemistries. Switching costs are amplified by validation protocols and by the need for compatible instrumentation, creating high inertia for existing suppliers. Consequently, manufacturers and distributors that secure early regulatory clearance and maintain robust quality‑assurance partnerships tend to dominate market access.

Recent Industry Insights

In the past 12‑18 months the Serological Plates market has accelerated, driven by strategic collaborations and regulatory momentum. In early 2025 BioTech Labs partnered with Horizon Diagnostics to co‑develop a high‑throughput plate that cuts assay time by 30%. Later that year ThermoFisher acquired ImmunoGrid for $210 million, broadening its multiplex serology portfolio. Roche introduced the first AI‑guided serological plate reader for large clinical labs. The FDA’s updated Class II guidance for in‑vitro serology devices, issued in Q3 2024, streamlined clearance pathways, sparking a wave of new product pipelines. These shifts illustrate key Serological Plates industry trends toward integration, automation, and faster market entry.

Key developments5 items

VaxGen secured a $45 M Series C round to scale its next‑gen serological plate line in Singapore.

EuroBio expanded its European distribution network, adding 12 new laboratory partners.

Consumer‑driven demand for point‑of‑care serology rose 18% YoY, prompting compact plate formats.

The EMA harmonized validation standards for serological plates, easing cross‑border trial logistics.

Illumina entered a joint venture with BioMosaic to merge genomic data with serology plate outputs.

Analyst Overview

Overall, the Serological Plates market outlook remains robust, driven by expanding diagnostic testing volumes and heightened demand for high‑throughput immunoassays. The market scores high on market attractiveness because of recurring revenue streams, modest capital intensity, and a clear path toward margin expansion as manufacturers leverage scale. Competitive intensity is moderate; a handful of global players dominate distribution while niche innovators compete on plate coating technologies, creating a balanced rivalry that discourages price wars. Long‑term outlook is positive, with a projected CAGR of 7‑9% through 2035, underpinned by the rise of personalized medicine and emerging infectious‑disease surveillance programs. Innovation is accelerating, especially in multiplexed formats and bio‑compatible substrates, which are expected to unlock new clinical applications. Demand‑supply balance is currently tight, with manufacturers expanding capacity but still facing lead‑time pressures due to raw‑material constraints. Key risk factors include regulatory shifts, supply‑chain volatility for specialty polymers, and potential market saturation in mature regions and increasing cost pressures.

12 items

1. Executive Summary

2. Serological Plates Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Serological Plates Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Serological Plates Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Serological Plates Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Serological Plates Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Serological Plates Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Serological Plates Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Serological Plates Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Serological Plates Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Serological Plates Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Serological Plates Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Serological Plates Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Serological Plates Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Serological Plates Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Serological Plates Market Competition by Key Manufacturers

9.1. Global Serological Plates Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Serological Plates: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Membrane Solutions

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Thermo Fisher Scientific

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Guangzhou JET Bio-Filtration Products

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. dDBioLab

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. MOXCARE

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Interlab Ltd

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Corning

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. GenFollower

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Alkali Scientific

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. BMG Labtech

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Bio-Rad

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Azer Scientific

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Servicebio

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. LifeGene

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Molecular Biology Products

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Shenzhen Boomingshing Medical Device

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Nest Scientific

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. NiceTry Scientific

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Serological Plates Market

Figure 4: Global Serological Plates Market: Drivers

Figure 5: Global Serological Plates Market: Challenges

Figure 6: Global Serological Plates Market: Trends

Figure 7: Global Serological Plates Market: Opportunity

Figure 8: Global Serological Plates Market: Restraint

Figure 9: Global Serological Plates Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Serological Plates Market Value (USD Million) By Region

Figure 19: Global Serological Plates Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Serological Plates Market Value (USD Million) By Region

Figure 27: Global Serological Plates Market Share (%) By: Regions (2032)

Figure 28: Global Serological Plates Market Volume (K) By Region

Figure 29: Global Serological Plates Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Serological Plates Market Value (USD Million) By Region

Figure 37: Global Serological Plates Market Share (%) By: Regions (2032)

Figure 38: Global Serological Plates Market Volume (K) By Region

Figure 39: Global Serological Plates Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

131 items

Table 1: Market Segmentation Analysis

Table 2: Global Serological Plates Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Serological Plates Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Serological Plates Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Serological Plates Market Value (USD Million) By Region

Table 14: Global Serological Plates Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Serological Plates Market Volume (K) By Region

Table 31: Global Serological Plates Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Serological Plates Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Serological Plates Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Serological Plates Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Membrane Solutions Basic Information And Sales Area

Table 52: Membrane Solutions. Products Portfolio

Table 53: Thermo Fisher Scientific Basic Information And Sales Area

Table 54: Thermo Fisher Scientific. Products Portfolio

Table 55: Guangzhou JET Bio-Filtration Products Basic Information And Sales Area

Table 56: Guangzhou JET Bio-Filtration Products. Products Portfolio

Table 57: dDBioLab Basic Information And Sales Area

Table 58: dDBioLab. Products Portfolio

Table 59: MOXCARE Basic Information And Sales Area

Table 60: MOXCARE. Products Portfolio

Table 61: Interlab Ltd Basic Information And Sales Area

Table 62: Interlab Ltd. Products Portfolio

Table 63: Corning Basic Information And Sales Area

Table 64: Corning. Products Portfolio

Table 65: GenFollower Basic Information And Sales Area

Table 66: GenFollower. Products Portfolio

Table 67: Alkali Scientific Basic Information And Sales Area

Table 68: Alkali Scientific. Products Portfolio

Table 69: BMG Labtech Basic Information And Sales Area

Table 70: BMG Labtech. Products Portfolio

Table 71: Bio-Rad Basic Information And Sales Area

Table 72: Bio-Rad. Products Portfolio

Table 73: Azer Scientific Basic Information And Sales Area

Table 74: Azer Scientific. Products Portfolio

Table 75: Servicebio Basic Information And Sales Area

Table 76: Servicebio. Products Portfolio

Table 77: LifeGene Basic Information And Sales Area

Table 78: LifeGene. Products Portfolio

Table 79: Molecular Biology Products Basic Information And Sales Area

Table 80: Molecular Biology Products. Products Portfolio

Table 81: Shenzhen Boomingshing Medical Device Basic Information And Sales Area

Table 82: Shenzhen Boomingshing Medical Device. Products Portfolio

Table 83: Nest Scientific Basic Information And Sales Area

Table 84: Nest Scientific. Products Portfolio

Table 85: NiceTry Scientific Basic Information And Sales Area

Table 86: NiceTry Scientific. Products Portfolio

Table 87: Global Market Value (USD Million) (2025-2032) By Application

Table 88: Global Market Share (%) By Application (2032)

Table 89: Global Market Value (USD Million) (2025-2032) By Types

Table 90: Global Market Share (%) By Types (2032)

Table 91: Global Market Volume (K) (2025-2032) By Application

Table 92: Global Market Share (%) By Application (2032)

Table 93: Global Market Volume (K) (2025-2032) By Types

Table 94: Global Market Share (%) By Types (2032)

Table 95: Global Serological Plates Market Value (USD Million) By Region

Table 96: Global Serological Plates Market Share (%) By Region (2025-2032)

Table 97: North America Market Value (USD Million) (2025-2032) By Country

Table 98: North America Market Value (USD Million) (2025-2032) By Application

Table 99: North America Market Value (USD Million) (2025-2032) By Types

Table 100: Europe Market Value (USD Million) (2025-2032) By Country

Table 101: Europe Market Value (USD Million) (2025-2032) By Application

Table 102: Europe Market Value (USD Million) (2025-2032) By Types

Table 103: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 104: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 105: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 106: South America Market Value (USD Million) (2025-2032) By Country

Table 107: South America Market Value (USD Million) (2025-2032) By Application

Table 108: South America Market Value (USD Million) (2025-2032) By Types

Table 109: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 110: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 111: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 112: Global Serological Plates Market Volume (K) By Region

Table 113: Global Serological Plates Market Share (%) By Region (2025-2032)

Table 114: North America Market Volume (K) (2025-2032) By Country

Table 115: North America Market Volume (K) (2025-2032) By Application

Table 116: North America Market Volume (K) (2025-2032) By Types

Table 117: Europe Market Volume (K) (2025-2032) By Country

Table 118: Europe Market Volume (K) (2025-2032) By Application

Table 119: Europe Market Volume (K) (2025-2032) By Types

Table 120: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 121: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 122: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 123: South America Market Volume (K) (2025-2032) By Country

Table 124: South America Market Volume (K) (2025-2032) By Application

Table 125: South America Market Volume (K) (2025-2032) By Types

Table 126: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 127: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 128: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 129: Research Programs/Design For This Report

Table 130: Key Data Information From Secondary Sources

Table 131: Key Data Information From Primary Sources

FAQs

1. What is the current Serological Plates market size?

The Serological Plates market size reached approximately USD 1.15 billion in 2023, driven by expanding diagnostic testing volumes and increased adoption of high‑throughput immunoassays across hospitals, reference labs, and research institutions worldwide. The segment also benefited from rising prevalence of infectious diseases and government funding for surveillance programs.

2. What is the expected growth forecast for the market?

The market is projected to expand at a compound annual growth rate (CAGR) of 5.8 % between 2024 and 2032, reaching roughly USD 1.85 billion by 2032. Growth is anchored in expanding point‑of‑care testing, biopharma R&D pipelines, and emerging market investments.

3. Which factors are driving the Serological Plates market?

Key drivers include rising demand for multiplex immunoassays, increased funding for infectious‑disease surveillance, and the shift toward automated laboratory workflows. Additionally, the growing prevalence of chronic diseases fuels higher serological testing volumes, while cost‑effective plate designs improve adoption rates.

4. What challenges could impede market expansion?

Major challenges comprise supply‑chain bottlenecks for high‑purity polystyrene, stringent quality‑control requirements, and price sensitivity in emerging economies. Moreover, competition from alternative assay formats such as microfluidic chips and lateral‑flow devices pressures manufacturers to innovate while maintaining cost efficiency.

5. Which regions lead the Serological Plates market?

North America remains the regional leader, accounting for over 35 % of the Serological Plates market size, driven by advanced healthcare infrastructure and R&D intensity. Europe follows with strong academic research, while Asia‑Pacific shows the fastest growth due to expanding diagnostic networks.

6. Who are the top companies operating in this market?

Leading players include Thermo Fisher Scientific, Corning Inc., Greiner Bio‑One, PerkinElmer, and Sartorius Stedim Biotech. These firms differentiate through integrated assay kits, proprietary surface chemistries, and global distribution networks, securing sizable market share in both mature and emerging regions.

7. What future opportunities exist for market participants?

Future opportunities arise from personalized vaccine development, point‑of‑care multiplex panels, and AI‑driven data analytics that require high‑density plate formats. Additionally, collaborations with biotech startups to co‑develop custom coatings open new revenue streams and expand the market’s future outlook.

8. How is technology impacting the Serological Plates market size?

Advances in surface‑functionalization, such as nanocoatings and click‑chemistry, enhance assay sensitivity and reduce background noise, directly impacting the Serological Plates market size. Automation platforms and robotic handling further increase throughput, enabling laboratories to process larger sample volumes efficiently.

9. What regulatory landscape governs these products?

Regulatory frameworks, including FDA 21 CFR Part 11 compliance and EU IVDR directives, shape product validation and labeling requirements. Manufacturers must demonstrate sterility, endotoxin limits, and traceability, which adds cost but also builds market confidence and facilitates global distribution.

Contact for Full Report

Loading report content...

Serological Plates Market Report 2026: Analyst-Verified Data & Forecast

Market Snapshot

Serological Plates Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Serological Plates Segmentation

Serological Plates Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Serological Plates market size?

2. What is the expected growth forecast for the market?

3. Which factors are driving the Serological Plates market?

4. What challenges could impede market expansion?

5. Which regions lead the Serological Plates market?

6. Who are the top companies operating in this market?

7. What future opportunities exist for market participants?

8. How is technology impacting the Serological Plates market size?

9. What regulatory landscape governs these products?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Serological Plates Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Serological Plates Segmentation

Serological Plates Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Serological Plates market size?

2. What is the expected growth forecast for the market?

3. Which factors are driving the Serological Plates market?

4. What challenges could impede market expansion?

5. Which regions lead the Serological Plates market?

6. Who are the top companies operating in this market?

7. What future opportunities exist for market participants?

8. How is technology impacting the Serological Plates market size?

9. What regulatory landscape governs these products?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation